Hologic (NSDQ:HOLX) announced that it acquired fibroid treatment developer Acessa Health in a deal worth approximately $80 million. Austin, Texas-based Acessa markets the Acessa ProVu fully integrated laparoscopic system for combining radiofrequency ablation with intra-abdominal ultrasound visualization and guidance mapping for treating women with symptomatic, benign uterine fibroids. Marlborough, Mass.-based Hologic said in a news release […]
acessahealth
Acessa Health appoints three new executives to leadership team
Acessa Health this week announced it added three new executives to its team. Shonu Gandhi was appointed VP of market access and clinical strategy. Her role will be focusing on improving patient access to the Acessa procedure by expanding payer coverage and clinical evidence. Gandhi has more than 10 years of experience and most recently […]
Acessa Health launches third-gen Acessa ProVu system
Acessa Health said today that it launched its third-generation Acessa ProVu system intended to treat uterine fibroid tumors with minimally-invasive laparoscopic radiofrequency ablation in the U.S. The Austin, Texas-based company added that the system has been used in its first procedures in the U.S. “I’ve used every generation of the Acessa family of products and […]
Acessa Health wins FDA nod for 3rd-gen ProVu
Acessa Health said today it won FDA 510(k) clearance for its third-gen Acessa ProVu radiofrequency ablation system intended for use in treating symptomatic uterine fibroids. The Austin, Texas-based company said the newly cleared system features ultrasound visualization and a guidance mapping system, and that it is intended to provide a safe alternative to hysterectomy procedures for […]
Second Sight Medical taps Blake as CFO | Personnel Moves – March 27, 2018
Second Sight Medical (NSDQ:EYES) said last week it named John Blake as its new chief financial officer, succeeding Thomas Miller who has held the position since 2014. Before joining Second Sight Medical, Blake acted as finance senior VP at Tyr Pharma, and has held positions with Volcano Corp and BD Biosciences, the company said. Blake worked with […]
Acessa Health touts Medicaid win
Acessa Health said today that 32 state Medicaid programs now provide access to the company’s Acessa procedure designed to treat uterine fibroids using radiofrequency ablation. The Acessa procedure, utilizing the Acessa system, is designed as a uterine sparing alternative to hysterectomy. The procedure can treat most sizes and locations of fibroids, including those in the uterine […]
Acessa Health touts data from 10-year review of uterine fibroid treatment
Acessa Health today touted data from a 10-year systematic review and meta-analysis of its Acessa system designed to treat uterine fibroids and comparable procedures, touting reduced blood loss, hospitalization time and readmission rates. Data from the 10-year review was presented at the MIS Week 2017 conference by Dr. Yelena Havryliuk of Weill Cornell Medical College. […]
Acessa Health closes bankruptcy buyout of Halt Medical, raises $30m
Acessa Health said today that it closed the bankruptcy buyout of Halt Medical and promptly raised a Series A round worth $30 million. The Acessa device is designed to treat uterine fibroids using radiofrequency ablation. Its successor namesake emerged after a Delaware federal bankruptcy judge earlier this month approved the bankruptcy sale, which was designed to keep the […]